Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Rev Mal Respir ; 21(5 Pt 3): 8S92-8, 2004 Nov.
Artículo en Francés | MEDLINE | ID: mdl-15803543

RESUMEN

Pneumonia amongst elderly people living in institutions is common and is a frequent cause of mortality and hospital admission. It is important to distinguish between prevention of viral pneumonia, which primarily consists of influenza vaccination programmes, and prevention of bacterial pneumonia. Prevention of influenza infection in institutions requires the vaccination of as many as possible of both residents and caregivers. In the event of a declared epidemic then amantadine can be used to reduce the severity of, and complication rate of, influenza infection. The indications for giving this therapy need to be balanced against potential side-effects, especially neurological ones. For the prevention of bacterial pneumonia risk factors such as immobility or impaired swallowing should be first identified and dealt with as necessary. Anti-pneumoncoccal vaccination may be considered, but on current evidence, the value of systematic vaccination of residents has not yet been established.


Asunto(s)
Hogares para Ancianos , Casas de Salud , Neumonía/microbiología , Neumonía/prevención & control , Anciano , Humanos , Vacunación
2.
Rev Mal Respir ; 19(5 Pt 1): 627-32, 2002 Oct.
Artículo en Francés | MEDLINE | ID: mdl-12473949

RESUMEN

Pneumonia amongst elderly people living in institutions is common and is a frequent cause of mortality and hospital admission. It is important to distinguish between prevention of viral pneumonia, which primarily consists of influenza vaccination programmes, and prevention of bacterial pneumonia. Prevention of influenza infection in institutions requires the vaccination of as many as possible of both residents and caregivers. In the event of a declared epidemic then amantadine can be used to reduce the severity of, and complication rate of, influenza infection. The indications for giving this therapy need to be balanced against potential side-effects, especially neurological ones. For the prevention of bacterial pneumonia risk factors such as immobility or impaired swallowing should be first identified and dealt with as necessary. Anti-pneumoncoccal vaccination may be considered, but on current evidence, the value of systematic vaccination of residents has not yet been established.


Asunto(s)
Vacunas contra la Influenza/uso terapéutico , Gripe Humana/complicaciones , Gripe Humana/prevención & control , Cuidados a Largo Plazo , Vacunas Neumococicas/uso terapéutico , Neumonía Bacteriana/prevención & control , Anciano , Amantadina/uso terapéutico , Antivirales/uso terapéutico , Cuidadores , Brotes de Enfermedades , Geriatría , Humanos , Medicina Preventiva , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA